← Back
$BBIO All transactions

BridgeBio Pharma, Inc.

M

$ Value

$882K

Shares

74,000

Price

$12

Filed

Sep 8

Insider

Name

MCCORMICK FRANK

Title

CIK

0001257809

Roles

Director

Transaction Details

Transaction Date

2025-09-05

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

157,275

Footnotes

Represents the weighted average sale price of the shares sold from $52.96 to $53.39 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | The stock option vests and becomes exercisable in three annual installments after February 21, 2023, with a final vesting date of February 21, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.

Filing Info

Accession No.

0001257809-25-000003

Form Type

4

Issuer CIK

0001743881

MCCORMICK FRANK's History

Date Ticker Type Value
2025-10-29 BBIO $7.3M
2025-10-29 BBIO $2.1M
2025-10-29 BBIO $236K
2025-10-29 BBIO $589K
2025-10-29 BBIO $3.0M
2025-10-27 BBIO $107K
2025-09-05 BBIO M $882K
2025-09-05 BBIO $3.9M
2025-09-05 BBIO M $0
2025-08-26 BBOT A $0

Other Insiders at BBIO (90d)

Insider Bought Sold Last
Kumar Neil
Chief Executive Officer
$6.0M 2026-04-10